Investigatory pathway and principles of patient selection for epilepsy surgery candidates: a systematic review.

Author: Ghaffari-RafiArash, Leon-RojasJose

Paper Details 
Original Abstract of the Article :
The predominant treatment for epilepsy is pharmacotherapy, yet 20-40% do not respond to anti-epileptic drugs. After becoming pharmacoresistant, some patients are worked-up to determine candidacy for epilepsy surgery. Despite the 2009 American Epilepsy Society guidelines, there is no broadly accepted...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7079385/

データ提供:米国国立医学図書館(NLM)

Epilepsy Surgery: Navigating the Desert of Treatment Options

Epilepsy, a neurological condition characterized by recurrent seizures, is a challenging desert to traverse for those who experience it. While pharmacotherapy is the primary treatment for epilepsy, many patients find that their seizures are resistant to medication. This research explores the investigatory pathway and principles of patient selection for epilepsy surgery, aiming to shed light on the process of determining candidacy for this surgical intervention.

Epilepsy Surgery: A Path Through the Desert of Pharmacoresistance

The study highlights the need for a standardized approach to evaluating patients for epilepsy surgery. The researchers reviewed existing guidelines and practices to identify common diagnostic pathways and selection criteria for epilepsy surgery candidates. The study emphasizes the importance of a multidisciplinary approach, involving neurologists, neurosurgeons, and other specialists, to ensure thorough evaluation and patient selection for surgery.

Choosing the Right Path: Navigating the Desert of Epilepsy Treatment Options

This study provides valuable insights into the process of evaluating patients for epilepsy surgery, highlighting the need for a comprehensive and standardized approach. It emphasizes the importance of careful patient selection to ensure that surgery is a viable and effective treatment option.

Dr. Camel's Conclusion

The desert of epilepsy can be a daunting landscape, with its unpredictable storms and shifting sands. This research offers a valuable guide for navigating the complex path of treatment options for epilepsy patients. By understanding the investigatory pathway and principles of patient selection for epilepsy surgery, healthcare professionals can better assist patients in finding their way out of the desert of pharmacoresistance and towards a brighter future.

Date :
  1. Date Completed 2020-08-10
  2. Date Revised 2020-08-10
Further Info :

Pubmed ID

32183734

DOI: Digital Object Identifier

PMC7079385

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.